Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

Transplant Proc. 2000 Mar;32(2):446-8. doi: 10.1016/s0041-1345(00)00842-3.

Authors

M Cantarovich¹, M Quantz, E Elstein, P Ergina, C Magnan, B de Varennes

Affiliation

¹ Royal Victoria Hospital, McGill University Health Center, Montréal, Québec, Canada.

PMID: 10715475
DOI: 10.1016/s0041-1345(00)00842-3

No abstract available

MeSH terms

Acute Disease
Antilymphocyte Serum / therapeutic use*
Cardiomyopathies / surgery
Cyclosporine / blood
Cyclosporine / pharmacokinetics*
Cyclosporine / therapeutic use*
Drug Administration Schedule
Drug Monitoring
Graft Rejection / drug therapy
Graft Rejection / epidemiology
Heart Transplantation / immunology
Heart Transplantation / physiology*
Humans
Immunosuppressive Agents / blood
Immunosuppressive Agents / pharmacokinetics*
Immunosuppressive Agents / therapeutic use
Male
Methylprednisolone / therapeutic use
Middle Aged

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Cyclosporine
Methylprednisolone